PharmGen Science, Inc. (004720.KS)
KRW 4370.0
(-1.47%)
KRW 4370.0
(-1.47%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.71 Billion KRW | -0.89% |
| 2022 | 20.9 Billion KRW | 37.28% |
| 2021 | 15.22 Billion KRW | -7.28% |
| 2020 | 16.41 Billion KRW | 19.15% |
| 2019 | 13.78 Billion KRW | 14.82% |
| 2018 | 12 Billion KRW | 0.57% |
| 2017 | 11.93 Billion KRW | -7.02% |
| 2016 | 12.83 Billion KRW | 47.17% |
| 2015 | 8.72 Billion KRW | -12.7% |
| 2014 | 9.99 Billion KRW | 28.21% |
| 2013 | 7.79 Billion KRW | 36.43% |
| 2012 | 5.71 Billion KRW | -5.18% |
| 2011 | 6.02 Billion KRW | -35.25% |
| 2010 | 9.3 Billion KRW | 27.91% |
| 2009 | 7.27 Billion KRW | -18.86% |
| 2008 | 8.96 Billion KRW | -26.41% |
| 2007 | 12.17 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 24.57 Billion KRW | 13.76% |
| 2024 Q1 | 21.59 Billion KRW | 4.28% |
| 2023 Q2 | 25.69 Billion KRW | 27.59% |
| 2023 Q3 | 24.97 Billion KRW | -2.79% |
| 2023 FY | 20.71 Billion KRW | -0.89% |
| 2023 Q1 | 20.13 Billion KRW | -3.66% |
| 2023 Q4 | 20.71 Billion KRW | -17.06% |
| 2022 Q3 | 20.56 Billion KRW | 16.89% |
| 2022 Q4 | 20.9 Billion KRW | 1.65% |
| 2022 FY | 20.9 Billion KRW | 37.28% |
| 2022 Q2 | 17.59 Billion KRW | 17.73% |
| 2022 Q1 | 14.94 Billion KRW | -1.86% |
| 2021 Q2 | 14.83 Billion KRW | -1.23% |
| 2021 Q4 | 15.22 Billion KRW | 8.58% |
| 2021 FY | 15.22 Billion KRW | -7.28% |
| 2021 Q3 | 14.02 Billion KRW | -5.46% |
| 2021 Q1 | 15.01 Billion KRW | -8.54% |
| 2020 FY | 16.41 Billion KRW | 19.15% |
| 2020 Q2 | 13.87 Billion KRW | -7.7% |
| 2020 Q1 | 15.03 Billion KRW | 9.07% |
| 2020 Q4 | 16.41 Billion KRW | 1.71% |
| 2020 Q3 | 16.14 Billion KRW | 16.37% |
| 2019 Q2 | 12.74 Billion KRW | 0.75% |
| 2019 FY | 13.78 Billion KRW | 14.82% |
| 2019 Q4 | 13.78 Billion KRW | 7.65% |
| 2019 Q3 | 12.8 Billion KRW | 0.41% |
| 2019 Q1 | 12.65 Billion KRW | 5.44% |
| 2018 Q3 | 14.21 Billion KRW | 0.41% |
| 2018 FY | 12 Billion KRW | 0.57% |
| 2018 Q1 | 12.26 Billion KRW | 2.8% |
| 2018 Q2 | 14.15 Billion KRW | 15.39% |
| 2018 Q4 | 12 Billion KRW | -15.57% |
| 2017 Q4 | 11.93 Billion KRW | -6.1% |
| 2017 FY | 11.93 Billion KRW | -7.02% |
| 2017 Q1 | 14.39 Billion KRW | 12.18% |
| 2017 Q2 | 13.25 Billion KRW | -7.97% |
| 2017 Q3 | 12.7 Billion KRW | -4.08% |
| 2016 Q2 | 10.88 Billion KRW | 16.93% |
| 2016 FY | 12.83 Billion KRW | 47.17% |
| 2016 Q3 | 12.01 Billion KRW | 10.34% |
| 2016 Q1 | 9.31 Billion KRW | 6.76% |
| 2016 Q4 | 12.83 Billion KRW | 6.85% |
| 2015 Q4 | 8.72 Billion KRW | -17.4% |
| 2015 Q3 | 10.55 Billion KRW | -7.63% |
| 2015 FY | 8.72 Billion KRW | -12.7% |
| 2015 Q1 | 10.5 Billion KRW | 5.17% |
| 2015 Q2 | 11.43 Billion KRW | 8.78% |
| 2014 Q3 | 7.15 Billion KRW | 16.9% |
| 2014 Q4 | 9.99 Billion KRW | 39.72% |
| 2014 Q2 | 6.11 Billion KRW | -11.26% |
| 2014 Q1 | 6.89 Billion KRW | -11.55% |
| 2014 FY | 9.99 Billion KRW | 28.21% |
| 2013 Q3 | 7.8 Billion KRW | 14.74% |
| 2013 FY | 7.79 Billion KRW | 36.43% |
| 2013 Q1 | 6 Billion KRW | 5.21% |
| 2013 Q2 | 6.8 Billion KRW | 13.2% |
| 2013 Q4 | 7.79 Billion KRW | -0.16% |
| 2012 Q2 | 6.02 Billion KRW | 7.49% |
| 2012 Q1 | 5.6 Billion KRW | -6.92% |
| 2012 FY | 5.71 Billion KRW | -5.18% |
| 2012 Q4 | 5.71 Billion KRW | -7.49% |
| 2012 Q3 | 6.17 Billion KRW | 2.44% |
| 2011 FY | 6.02 Billion KRW | -35.25% |
| 2011 Q2 | 8.32 Billion KRW | -2.91% |
| 2011 Q1 | 8.57 Billion KRW | -7.8% |
| 2011 Q4 | 6.02 Billion KRW | -19.05% |
| 2011 Q3 | 7.44 Billion KRW | -10.63% |
| 2010 FY | 9.3 Billion KRW | 27.91% |
| 2010 Q1 | 9.45 Billion KRW | 29.97% |
| 2010 Q2 | 10.03 Billion KRW | 6.18% |
| 2010 Q3 | 10.09 Billion KRW | 0.58% |
| 2010 Q4 | 9.3 Billion KRW | -7.84% |
| 2009 Q2 | 9.43 Billion KRW | -2.17% |
| 2009 Q1 | 9.64 Billion KRW | 7.56% |
| 2009 Q4 | 7.27 Billion KRW | -17.06% |
| 2009 Q3 | 8.76 Billion KRW | -7.02% |
| 2009 FY | 7.27 Billion KRW | -18.86% |
| 2008 Q3 | 10.38 Billion KRW | 4.02% |
| 2008 Q2 | 9.98 Billion KRW | 11.35% |
| 2008 FY | 8.96 Billion KRW | -26.41% |
| 2008 Q4 | 8.96 Billion KRW | -13.73% |
| 2008 Q1 | 8.96 Billion KRW | -26.35% |
| 2007 Q2 | 9.08 Billion KRW | 11.23% |
| 2007 Q4 | 12.17 Billion KRW | 42.88% |
| 2007 Q3 | 8.52 Billion KRW | -6.18% |
| 2007 FY | 12.17 Billion KRW | 0.0% |
| 2007 Q1 | 8.16 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Daewoong Co., Ltd. | 352.34 Billion KRW | 94.121% |
| Wooridul Huebrain Limited | 9.23 Billion KRW | -124.254% |